MedPath

NMES for Rehab After Surgery

Not Applicable
Completed
Conditions
Surgery
Vascular Diseases
Interventions
Device: Revitive Medic Neuromuscular Stimulation Device
Device: Revitive Medic Neuromuscular Stimulation Device (Sham)
Registration Number
NCT04784962
Lead Sponsor
Imperial College London
Brief Summary

A randomised pilot study assessing the acceptability and feasibility of utilising neuromuscular stimulation devices to enhance post-operative rehabilitation and recovery after general, vascular and urological surgery procedures.

Detailed Description

Patients undergoing inpatient rehabilitation after general, vascular or urological surgery will be invited to take part in a randomised study utilising either sham or active neuromuscular stimulation devices to enhance post-operative rehabilitation and physiotherapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention ArmRevitive Medic Neuromuscular Stimulation DeviceStandard rehabilitation care including physiotherapy + Adjunctive Neuromuscular Stimulation Device Usage
Control ArmRevitive Medic Neuromuscular Stimulation Device (Sham)Sham device
Primary Outcome Measures
NameTimeMethod
Safety and Acceptability of NMES as an adjunct for rehabilitationAt discharge from hospital (completion of study) - up to 28 days

Qualitiative assessment of participant satisfaction and acceptance of NMES device as an adjunct to standard rehabilitation via semi-structured interview

Secondary Outcome Measures
NameTimeMethod
Time to return to baseline mobility and independenceAt discharge from hospital (completion of study) - up to 28 days

Time in days to return to pre-operative mobility and independence

Rockwood Frailty IndexAt discharge from hospital (completion of study) - up to 28 days

Frailty index scoring tool at entry and exit of study

Standing for >1 minuteAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Walking >50mAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Generic Quality of life - EQ VASAt discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the EuroQol Visual Analogue Scale

6 Minute WalkAt discharge from hospital (completion of study) - up to 28 days

Distance walked in 6 minutes at entry and exit of study

Compliance with device usageAt discharge from hospital (completion of study) - up to 28 days

User compliance with NMES device as assessed with usage diary and qualitative feedback

Incremental cost-utility ratio, comparing NMES with standard careAt discharge from hospital (completion of study) - up to 28 days

Cost-effectiveness analysis

Length of stayAt discharge from hospital (completion of study) - up to 28 days

Hospital Length of stay

Time taken to achieve - Sitting for >5 minutesAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Hospital Resource useAt discharge from hospital (completion of study) - up to 28 days

Contacts with rehabilitation professionals during the using of NMES

Generic Quality of life - SF-36At discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the Short Form 36 health profile

Barthel IndexAt discharge from hospital (completion of study) - up to 28 days

Scoring tool of independence at entry and exit of study

Satisfaction with deviceAt discharge from hospital (completion of study) - up to 28 days

User satisfaction with NMES device assessed by qualitative feedback and assessment

Timed Up and GoAt discharge from hospital (completion of study) - up to 28 days

Time taken to stand and walk from sitting in a chair at entry and exit of study

Q FrailtyAt discharge from hospital (completion of study) - up to 28 days

Frailty assessment scale at entry and exit of study

Generic Quality of life - EQ-5DAt discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the EuroQol 5 Domain (EQ-5D) Health Metric

Functional Independence MeasureAt discharge from hospital (completion of study) - up to 28 days

Scoring tool of ability to function independently at entry and exit of study

Trial Locations

Locations (1)

Imperial College Healthcare NHS Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath